CD
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up (NCT03487900) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2018-03-13 |
| Crohn's Disease Endoscopic REmission Definition in an Objective Way (NCT03498625) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2018-03-13 |
| Changing the coUrse of cRohn's Disease With an Early Use of Adalimumab (NCT03306446) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2015-03-17 |
| Predictive Factors of ANTI-TNF Response in Luminal Crohn's Disease Complicated by Abscess (NCT02856763) | Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives | 2013-04-01 |
| Bacteriotherapy in Pediatric Inflammatory Bowel Disease (NCT01757964) | David Suskind | 2012-12-01 |
Track CD automatically
Every clearance here is in the API, with alerts when new ones post.